Krishna Institute of Medical Sciences Limited (BOM:543308)
655.15
-5.30 (-0.80%)
At close: Jun 9, 2025
BOM:543308 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 3,845 | 3,101 | 3,363 | 3,327 | 2,012 | Upgrade
|
Depreciation & Amortization | 1,772 | 1,403 | 1,245 | 701.16 | 682.29 | Upgrade
|
Other Amortization | - | 62.73 | 47.5 | 25.57 | 13.07 | Upgrade
|
Loss (Gain) From Sale of Assets | -109 | -3.76 | -6.1 | 27.17 | 10.79 | Upgrade
|
Loss (Gain) From Sale of Investments | -48 | -18.43 | -11.83 | -95.1 | - | Upgrade
|
Loss (Gain) on Equity Investments | - | 2.71 | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | 130 | -14.55 | -115.43 | 44.57 | 47.03 | Upgrade
|
Other Operating Activities | 997 | 523.62 | 491.22 | -45.29 | 652.89 | Upgrade
|
Change in Accounts Receivable | -934 | -402.91 | -628.1 | -232.74 | 177.46 | Upgrade
|
Change in Inventory | -133 | -65.79 | 64.7 | -123.42 | 62.92 | Upgrade
|
Change in Accounts Payable | 620 | 499.42 | -410.83 | 101.18 | 239.21 | Upgrade
|
Change in Other Net Operating Assets | -322 | 123.59 | 281.42 | -489.7 | -338.11 | Upgrade
|
Operating Cash Flow | 5,818 | 5,211 | 4,321 | 3,240 | 3,560 | Upgrade
|
Operating Cash Flow Growth | 11.65% | 20.60% | 33.35% | -8.97% | 76.66% | Upgrade
|
Capital Expenditures | -10,089 | -6,473 | -5,745 | -1,703 | -944.26 | Upgrade
|
Sale of Property, Plant & Equipment | 472 | 14.14 | 26.3 | 3.18 | 8.42 | Upgrade
|
Cash Acquisitions | -1,757 | - | -1,477 | -11.3 | -352.73 | Upgrade
|
Divestitures | - | - | 2 | - | - | Upgrade
|
Investment in Securities | 398 | -822.37 | 1,599 | -2,538 | -2,296 | Upgrade
|
Other Investing Activities | -186 | -244.02 | 125.54 | 133.86 | 42.56 | Upgrade
|
Investing Cash Flow | -11,162 | -7,526 | -5,469 | -4,115 | -3,542 | Upgrade
|
Short-Term Debt Issued | 288 | 714.17 | - | - | 338.03 | Upgrade
|
Long-Term Debt Issued | 8,487 | 4,593 | 3,894 | 1,240 | 455.05 | Upgrade
|
Total Debt Issued | 8,775 | 5,307 | 3,894 | 1,240 | 793.08 | Upgrade
|
Short-Term Debt Repaid | - | - | -399.51 | -625 | - | Upgrade
|
Long-Term Debt Repaid | -968 | -500.39 | -2,273 | -1,805 | -1,374 | Upgrade
|
Total Debt Repaid | -968 | -500.39 | -2,673 | -2,430 | -1,374 | Upgrade
|
Net Debt Issued (Repaid) | 7,807 | 4,807 | 1,221 | -1,190 | -580.49 | Upgrade
|
Issuance of Common Stock | - | - | - | 1,917 | 950.23 | Upgrade
|
Other Financing Activities | -2,376 | -2,639 | -1,024 | -116.73 | -271.55 | Upgrade
|
Financing Cash Flow | 5,431 | 2,168 | 196.42 | 609.99 | 98.19 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 4 | - | 1,311 | 0.01 | - | Upgrade
|
Net Cash Flow | 91 | -147.2 | 359.77 | -264.95 | 116.15 | Upgrade
|
Free Cash Flow | -4,271 | -1,263 | -1,424 | 1,537 | 2,615 | Upgrade
|
Free Cash Flow Growth | - | - | - | -41.23% | 74.92% | Upgrade
|
Free Cash Flow Margin | -14.07% | -5.05% | -6.48% | 9.31% | 19.67% | Upgrade
|
Free Cash Flow Per Share | -10.68 | -3.15 | -3.56 | 3.87 | 6.87 | Upgrade
|
Cash Interest Paid | 1,498 | 828.7 | 337.43 | 116.72 | 271.55 | Upgrade
|
Cash Income Tax Paid | 1,414 | 1,402 | 972.35 | 1,269 | 377.44 | Upgrade
|
Levered Free Cash Flow | -4,463 | -2,216 | -2,393 | 1,303 | 1,821 | Upgrade
|
Unlevered Free Cash Flow | -3,898 | -1,925 | -2,210 | 1,403 | 2,004 | Upgrade
|
Change in Net Working Capital | -633.01 | 7.14 | 728.78 | 415.59 | -358.09 | Upgrade
|
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.